These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antimicrobial salvage therapy for native valve MRSA endocarditis. Cortes J, Sagar AS, Lee Y, Sandhu U, Boka K. J Antimicrob Chemother; 2017 Jun 01; 72(6):1841-1842. PubMed ID: 28333236 [No Abstract] [Full Text] [Related]
8. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis. Vernadakis S, Saner FH, Rath PM, Kaiser GM, Mathe Z, Treckmann J, Paul A. Transpl Infect Dis; 2009 Aug 01; 11(4):346-8. PubMed ID: 19497075 [Abstract] [Full Text] [Related]
9. In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates. Davis KP, McDermott LA, Snydman DR, Aldridge BB. Microbiol Spectr; 2024 Aug 06; 12(8):e0097624. PubMed ID: 38916355 [Abstract] [Full Text] [Related]
10. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches. Holubar M, Meng L, Deresinski S. Infect Dis Clin North Am; 2016 Jun 06; 30(2):491-507. PubMed ID: 27208769 [Abstract] [Full Text] [Related]
14. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G. J Antimicrob Chemother; 2011 Apr 06; 66(4):863-6. PubMed ID: 21393213 [Abstract] [Full Text] [Related]
16. Development of daptomycin resistance during therapy in a patient with methicillin-resistant Staphylococcus aureus endocarditis: A case report. Sotillo A, Paño-Pardo JR, López-Quintana B, Gómez-Gil R. Enferm Infecc Microbiol Clin; 2016 Oct 06; 34(8):534-5. PubMed ID: 26778103 [No Abstract] [Full Text] [Related]
17. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G. Antimicrob Agents Chemother; 2007 Sep 06; 51(9):3397-400. PubMed ID: 17591849 [Abstract] [Full Text] [Related]
18. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia. Barber KE, Rybak MJ, Sakoulas G. J Antimicrob Chemother; 2015 Jan 06; 70(1):311-3. PubMed ID: 25125677 [No Abstract] [Full Text] [Related]
19. Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon. Sundaragiri PR, Vallabhajosyula S, Haddad TM, Esterbrooks DJ. BMJ Case Rep; 2015 Nov 03; 2015():. PubMed ID: 26531738 [Abstract] [Full Text] [Related]